876296-50-3Relevant academic research and scientific papers
New, potent, selective, and short-acting peptidic V1a receptor agonists
Wi?niewski, Kazimierz,Galyean, Robert,Tariga, Hiroe,Alagarsamy, Sudarkodi,Croston, Glenn,Heitzmann, Joshua,Kohan, Arash,Wi?niewska, Halina,Laporte, Régent,Rivière, Pierre J-M.,Schteingart, Claudio D.
supporting information; experimental part, p. 4388 - 4398 (2011/09/14)
[Arg8]vasopressin (AVP) produces vasoconstriction via V 1a receptor (V1aR)-mediated vascular smooth muscle cell contraction and is being used to increase blood pressure in septic shock, a form of vasodilatory hypotension.
